Showing 13,941 - 13,960 results of 123,298 for search '(( 2 d decrease ) OR ( 5 ((((teer decrease) OR (a decrease))) OR (mean decrease)) ))', query time: 2.07s Refine Results
  1. 13941

    Expression levels of myosin heavy chain and AMPK-PGC-1α pathway in the skeletal muscles. by Shinichiro Yamada (3600374)

    Published 2016
    “…<p>The mRNA expression levels of <i>MYH1</i> (encoding MHC type IIx), <i>MYH2</i> (encoding MHC type IIa), and <i>MYH7</i> (encoding MHC type I) normalized to β2-microglobulin levels in the intercostal muscles of SBMA (<i>n</i> = 5) and ALS (<i>n</i> = 5) subjects (A–C). …”
  2. 13942

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”
  3. 13943

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”
  4. 13944

    Discovery of an Orally Active PDE1 Inhibitor for Disease-Modifying Treatment of Postmenopausal Osteoporosis via Dual Anabolic-Antiresorptive Mechanisms by Farman M. Abbasi (22318766)

    Published 2025
    “…Current treatments, such as teriparatide, boost bone formation but also elevate resorption, limiting their long-term effectiveness. We discovered 3-butyl-5,6,7,8-tetrahydrobenzo[4,5]thieno[2,3-<i>d</i>]pyrimidin-4(3<i>H</i>)-one <b>(5cc)</b>, an orally active phosphodiesterase-1 (PDE1) inhibitor aimed at restoring this balance. …”
  5. 13945

    Complete ELICIT TAC data. by Godfrey Guga (12152390)

    Published 2023
    “…We tested 5,479 stool samples at time points across the study for 34 enteropathogens using quantitative PCR.…”
  6. 13946

    ELICIT TAC data dictionary. by Godfrey Guga (12152390)

    Published 2023
    “…We tested 5,479 stool samples at time points across the study for 34 enteropathogens using quantitative PCR.…”
  7. 13947
  8. 13948

    Vitamin D and Risk of Multiple Sclerosis: A Mendelian Randomization Study by Lauren E. Mokry (787325)

    Published 2015
    “…MR analyses found that each genetically determined one-standard-deviation decrease in log-transformed 25OHD level conferred a 2.0-fold increase in the odds of MS (95% CI: 1.7–2.5; <i>p</i> = 7.7 × 10<sup>−12</sup>; <i>I</i><sup>2</sup> = 63%, 95% CI: 0%–88%). …”
  9. 13949

    Neither ASICs nor TRPV1 activities are affected by depletion of PI(3,4,5)P<sub>3</sub>. by Hae-Jin Kweon (525019)

    Published 2015
    “…<p>(A) CF-PTEN is rapidly recruited to the plasma membrane anchor LDR by dimerization of FRB and FKBP upon addition of rapamycin, and the PD domain of CF-PTEN specifically dephosphorylates PI(3,4,5)P<sub>3</sub> to PI(4,5)P<sub>2</sub>. …”
  10. 13950
  11. 13951
  12. 13952

    PrioV3 and ICSM35 antibodies inhibit accumulation of PrP<sup>Sc</sup> in ScN2a cells. by Daryl Rhys Jones (351314)

    Published 2013
    “…<p>ScN2a cells were incubated for 24 hours at 37°C (5% CO<sub>2</sub>) with 1 or 25 µg PrioV3 and ICSM35. 25 µg NCS (Normal camel serum), and BRIC126-treated as well as untreated cells were also included. …”
  13. 13953

    LARP1 regulates Netrin-1 microsomal translation. by Marie-Laure Plissonnier (337713)

    Published 2016
    “…LARP1 depletion decreases the expression of Netrin-1 protein in microsomes in Huh7.5 cells. …”
  14. 13954
  15. 13955
  16. 13956
  17. 13957
  18. 13958

    Characterization of LNCaP cell growth cultured within biomimetic hydrogels in normal growth media, RPMI and 10% FBS. by Shirly Sieh (139080)

    Published 2012
    “…<p>(A) Growth curves of LNCaP cells over 7 days for 2D cultures (left) and 28 days for 3D cultures (right) in normal growth media measured by total DNA content (mean ± SE). …”
  19. 13959
  20. 13960

    Epidermal Growth Factor Receptor-Dependent Mutual Amplification between Netrin-1 and the Hepatitis C Virus by Marie-Laure Plissonnier (337713)

    Published 2016
    “…Knockdown and forced expression experiments identified the receptor uncoordinated receptor-5 (UNC5A) as an antagonist of the Netrin-1 signal, though it did not affect the death of HCV-infected cells. …”